Search Results - "Windsheimer, Jorg"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
  2. 2
  3. 3

    Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting by Trojano, Maria, Kneebone, Chris, Lechner-Scott, Jeannette, Saines, Noel, Plummer, Chris, Delvaux, Valérie, Van Pesch, Vincent, Dubois, Benedicte, D'Hooghe, Marie, Lysandropoulos, Andreas, Denayer, Pierre, Bureau, Michel, Howse, David, Lapierre, Yves, MacLean, Gregg, Bhan, Virender, Havrdova, Eva, Novotna, Alena, Vachova, Marta, Rehankova, Adela, Psenica, Petr, Ulehlova, Veronika, Färkkilä, Markus, Taneli, Sarasoja, Koivisto, Keijo, Seppä, Juha Matti, Airas, Laura, Colamarino, Renato, Kopf, Audrey, Verier, Albert, Suceveanu, Manuel, Marcel, Sebastien, Derouiche, Faycal, Coustans, Marc, Berroir, Stephane, Larrieu, Jean-Marc, Kwiatkowski, Arnaud, Seiller, Nicolas, Bergmann, Arnfin, Scholz, Peter, Prantl, Martin, Zellner, Ruth, Link, Andreas, Drews, Joachim, Neudert, Christian, Masri, Said, Landefeld, Harald, Schmidt, Stephan, Gossling, Jens, Schenk, Christoph, Eder, Hans-Thomas, Meuth, Sven, Peglau, Ines, Kukowski, Borries, Augspach-Hofmann, Regine, Gunther, Stefan, Horn, Rolf, Horn, Markus, Hinse, Paul, Wenzel, Wilhelm, Botefur, Ingolf C., Reifschneider, Gerd, Rauer, Sebastian, Harms, Lutz, Cursiefen, Simone, Haas, Judith, Rohm, Eva, Sailer, Michael, Bause, Eberhard, Domke, Sylke, Hoffman, Frank, Gramsl, Georg, Bitsch, Andreas, Harmjanz, Arndt D., Kieseier, Bernd C., Kirsch, Michael, Berthele, Achim, Mitsikostas, Dimosthenis, Kodounis, Antonios, Plaitakis, Andreas, Kyritsis, Athanassios, Tavernarakis, Antonios, Lugaresi, Alessandra, Wittebol, M.C., van Golde, A.E.L., van Diepen, A.J.H., Verheul, G.A.M., Verhagen, W.I.M., Hupperts, R.M.M., Myhr, Kjell Morten, Hognestad, Tone, Hogenesch, Roelfien Ida, Ingvaldsen, Teis Barclay, Guerra, José Manuel Costa, Marques, Pinto, Urtaza, Javier Olascoaga, Wilson, Martin, Osei-Bonsu, Michael, Belhag, Mohamed, Duddy, Martin

    Published in Multiple sclerosis and related disorders (01-08-2018)
    “…•This long-term study examined the effects of natalizumab treatment at 5.5 years.•Disability worsening events confirmed at 24 weeks may not be sustained at 48…”
    Get full text
    Journal Article
  4. 4
  5. 5